In contrast, our findings for IL-17A, showing a marked decline with increasing tumor grade (approaching statistical significance with p = 0.095 in ANOVA), align with literature suggesting its more prominent expression in well-differentiated tumors and a potentially favorable prognostic role in early stages [49]. The gene discussed is IL17A; the disease is neoplasm.